International Journal of Clinical Research

Objective: To clarify the effect of using early warning scores in the treatment of pediatric dwarfism with growth hormone. Method: A total of 68 patients who met the diagnostic criteria for pediatric dwarfism based on comprehensive clinical examination results from February 2023 to February 2024 were included in the study. After random numbering, each patient was randomly assigned to two groups: a control group with 35 patients and an observation group with 33 patients. The control group received routine intervention, while the observation group received early childhood warning score intervention. The effects of different interventions were compared and analyzed. After the intervention, the proportion of total adverse events in the observation group was lower, with a P-value of<0.05, indicating a significant statistical difference. After intervention, the clinical indicators in the observation group had higher values, with P values<0.05, indicating a significant statistical difference. Conclusion: The application of early childhood warning scores in growth hormone therapy for children with dwarfism is beneficial in reducing the risk of adverse events and improving clinical indicators.

Pediatric dwarfism; Growth hormone; Early Warning Score for Children